Related Experiment Video
Updated: Feb 13, 2026

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
Published on: April 11, 2018
Serum C-reactive Protein and Neutrophil/Lymphocyte Ratio After Neoadjuvant Radiotherapy in Soft Tissue Sarcoma
Mio Yanagisawa1, Alicia A Gingrich1, Sean Judge1
1Division of Surgical Oncology, Department of Surgery, UC Davis School of Medicine, Sacramento, CA, U.S.A.
Background/Aim:
The predictive value of serum C-reactive protein (CRP) and neutrophil/lymphocyte (N/L) ratio in soft tissue sarcoma (STS) patients receiving neoadjuvant radiotherapy (RT) has not been analyzed.
Patients And Methods:
From 2007 to 2015, we identified 98 STS patients from a prospective database. Using multivariate analysis, we analyzed CRP and N/L ratios as predictors of overall survival (OS).
Results:
Mean age of patients was 59 years, 46% were female, and 55% of tumors were located at the extremity. A total of 15 histologies were represented. Fifty percent received preoperative RT. Except for extremity location, characteristics were similar between the preoperative RT and upfront surgery cohorts, including baseline CRP levels and N/L ratios. Multivariate analysis of upfront surgery revealed histological grade, tumor size, and baseline N/L ratio to be predictors of OS, while for preoperative RT, baseline CRP and N/L ratio were not predictive.
Conclusion:
Baseline CRP and N/L ratio did not predict poor clinical outcome in STS patients receiving neoadjuvant RT.
Related Concept Videos
Poisson's Ratio
Odds Ratio
Hazard Ratio
For example, in a clinical trial...
Cross-reactivity
Reactivity of Enols
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

